Saturday, December 2, 2023
Read Overview
Supported by an independent educational grant from
Akili Interactive Labs, Inc.
Supported by an independent educational grant from
Alkermes, Inc.
Supported by an independent educational grant from
Cerevel Therapeutics
Supported by an independent educational grant from
Myriad Genetics
Supported by an independent educational grant from
Corium, Inc.
Supported by an independent educational grant from
Pear Therapeutics, Inc.
Supported by an independent educational grant from
Sunovion Pharmaceuticals, Inc
Developed through a partnership between Medscape, American Academy of Clinical Psychiatrists, and Current Psychiatry.
Chair
Associate Clinical Professor
Washington University School of Medicine
President, Midwest Research Group
President-Elect
APSARD - American Professional Society for ADHD and Related Disorders
St. Louis, Missouri
Planning Committee Member
Program Co-Chair
Professor of Psychiatry and Anesthesiology
Associate Chair for Education Wayne State University
Detroit, Michigan
Planning Committee Member
President
American Academy of Clinical Psychiatrists (AACP)
Professor of Psychiatry
University of Iowa Carver College of Medicine
Iowa City, Iowa
Planning Committee Member
David C. Wilson Professor and Chair
Department of Psychiatry and Neurobehavioral Sciences
Professor
Clinical Obstetrics and Gynecology
University of Virginia
Charlottesville, Virginia
Planning Committee Member
Professor of Psychiatry
Harvard Medical School
Associate Director
Center for Women's Mental Health
Medical Director, CTNI
Massachusetts General Hospital
Boston, Massachusetts
Planning Committee Member
Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York
Planning Committee Member
Editor-in-Chief
CURRENT PSYCHIATRY
Past President
American Academy of Clinical Psychiatrists (AACP)
Vice-Chair for Faculty Development and Mentorship
Professor of Psychiatry, Neurology, & Neuroscience
Director, Neuropsychiatry and Schizophrenia Programs
University of Cincinnati College of Medicine
Cincinnati, Ohio
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie, Inc.; Acadia Pharmaceuticals, Inc.; Alkermes, Inc.; Axsome Therapeutics, Inc.; Corium International, Inc.; Eisai, Inc.; Ironshore Pharmaceuticals Inc.; Intra-Cellular Therapies, Inc.; Janssen Pharmaceuticals; Lundbeck, Inc.; Neos Therapeutics, Inc.; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Redax; Roche; Rhodes Pharmaceuticals L.P.; Sage Therapeutics, Inc.; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc.; Teva Neuroscience, Inc.; Tris Pharma, Inc.
Received grants for clinical research from: AbbVie, Inc.; Alkermes, Inc.; Corium International, Inc.; Eisai, Inc.; Intra-Cellular Therapies, Inc.; Ironshore Pharmaceuticals, Inc.; Janssen Pharmaceuticals; Lundbeck, Inc.; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc.; Tris Pharma, Inc.
Contracted researcher for: AbbVie, Inc.; Acadia Pharmaceuticals, Inc.; Alkermes, Inc.; Akili Interactive Labs, Inc.; Axsome Therapeutics, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Emalex Biosciences; Idorsia Pharmaceuticals, Ltd.; Janssen Pharmaceuticals; Karuna Therapeutics; Lumos Labs; Medgenics; NLS-1 Pharma AG; Redax; Relmada Therapeutics, Inc.; Roche; Sage Therapeutics, Inc.; Sirtsei; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc.; Teva Neuroscience, Inc.
Has disclosed no relevant financial relationships.
Has disclosed no relevant financial relationships.
Has disclosed the following relevant financial relationships:
Served as an Advisor or consultant for: AbbVie, Inc.; Acadia Pharmaceuticals, Inc.; Alkermes, Inc.; Allergan; AMAG Pharmaceuticals, Inc.; Astellas Pharma, Inc.; Brii Biosciences; Fabre-Kramer Pharmaceuticals, Inc.; Field Trip Health; Janssen Pharmaceuticals; Lundbeck, Inc.; MINDCURE Health Inc.; Ovoca Bio PLC; Praxis Precision Medicines; PureTech Health; S1 Biopharma, Inc.; Sage Therapeutics, Inc.; Takeda Pharmaceuticals North America, Inc.; Vella Bioscience, Inc.; WCG MedAvante-ProPhase
Received grants for clinical research from: Daré Biosciences, Inc.; Endoceutics, Inc.; Janssen Pharmaceuticals; Praxis Precision Medicines; Relmada Therapeutics, Inc.; Sage Therapeutics, Inc.
Stock options for: Euthymics Bioscience, Inc.; S1 Biopharma, Inc.
Has disclosed the following relevant financial relationships:
Consultant or advisor for: Eliem Therapeutics, Inc.; Janssen Pharmaceuticals (Johnson & Johnson); Neurocrine Biosciences, Inc.; Novartis Pharmaceuticals; Sage Therapeutics, Inc.
Research funding from: Alkermes, Inc.; Aurobindo Pharma; AuroMedics Pharma LLC; JayMac Pharmaceuticals, LLC.; Janssen Pharmaceuticals (Johnson & Johnson); Otsuka Pharmaceutical Co., Ltd.; Sage Therapeutics, Inc.; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals; Teva Pharmaceutical Industries, Ltd.
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: BioXcel Therapeutics; Jazz Pharmaceuticals, Inc.; Lundbeck, Inc.; Otsuka Pharmaceuticals, Co., Ltd.; Sage Therapeutics, Inc.; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.
Served as a speaker or a member of a speakers bureau for: AbbVie, Inc.; Alkermes, Inc.; Intra-Cellular Therapies, Inc.; Sunovion Pharmaceuticals, Inc.
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie, Inc.; Acadia Pharmaceuticals, Inc.; Alkermes, Inc.; Avanir Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Cerevel Therapeutics; Intra-Cellular Therapies, Inc.; Indivior PLC; Janssen Pharmaceuticals; Karuna Therapeutics; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals, Inc.; Teva Neuroscience, Inc.
Served as a speaker or a member of a speakers bureau for: AbbVie, Inc.; Acadia Pharmaceuticals, Inc.; Alkermes, Inc.; Intra-Cellular Therapies, Inc.; Indivior PLC; Janssen Pharmaceuticals; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals, Inc.; Teva Neuroscience, Inc.
